Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside is a synthetic aminoglycoside analog and small molecule. It is structurally related to the H-disaccharide antigen and has been studied primarily as a chemical probe in research on substrate recognition by blood group A and B glycosyltransferases. The compound features an octyl group attached to a modified disaccharide core with amino and deoxygenated sugar residues. There are no known approved therapeutic indications or clinical uses for this compound; it remains experimental and is mainly used in biochemical studies[1][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside.